Oxidative stress: New approaches to diagnosis and prognosis in atherosclerosis

American Journal of Cardiology

Volumn 91, Issue 3 SUPPL., 2003, Pages 12-16

  Heinecke, Jay W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; HYPOCHLOROUS ACID; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; REACTIVE NITROGEN SPECIES; TYROSINE;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MASS SPECTROMETRY; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS;

EID: 0037421493     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03145-4     Document Type: Conference Paper

References (36)

1. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
2. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1790.
3. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low density lipoprotein hypothesis . Atherosclerosis. 141:1998;1-15.
4. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest. 109:2002;1311-1319.
5. Gaut J.P., Yeh G.C., Tran H.D., Byun J., Henderson J.P., Richter G.M., Belaaoua A., Hotchkiss R.S., Heinecke J.W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A. 98:2001;11961-11966.
6. Rosenfeld M.E., Palinski W., Yla-Herttuala S., Butler S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein-B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
7. Hurst J.K., Barette W.C. Jr. Leukocyte oxygen activation and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol. 24:1989;271-328.
8. Daugherty A., Rateri D.L., Dunn J.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 94:1994;437-444.
9. Brown K.E., Brunt E.M., Heinecke J.W. Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. Am J Pathol. 159:2001;2081-2088.
10. Harrison J.E., Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem. 251:1976;1371-1376.
11. Heinecke J.W., Li W., Francis G.A., Goldstein J.A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative crosslinking of proteins. J Clin Invest. 91:1993;2866-2872.
12. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 272:1997;1433-1436.
13. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem. 272:1997;3520-3526.
14. Morrow J.D., Roberts L.J. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol. 51:1996;1-9.
15. Hazen S.L., Hsu F.F., Mueller D.M., Crowley J.R., Heinecke J.W. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest. 98:1996;1283-1289.
16. Heinecke J.W., Hsu F.F., Crowley J.R., Hazen S.L., Leeuwenburgh C., Mueller D.M., Rasmussen J.E., Turk J. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry sensitive and quantitative assays for oxidized amino acids in proteins and tissues . Methods Enzymol. 300:1998;124-144.
17. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 99:1997;2075-2081.
18. McCloskey JA. Mass spectrometry. San Diego, Academic Press, 1990.
19. Heinecke J.W., Li W., Daehnke H.L., Goldstein J.A. o,o′-Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem. 268:1993;4069-4077.
20. McCormick M.L., Gaut J.P., Lin T., Britigan B.E., Buettner G.R., Heinecke J.W. Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase. J Biol Chem. 273:1998;32030-32037.
21. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233:1994;229-240.
22. Huggins T.G., Wells-Knecht M.C., Detorie N.A., Baynes J.W., Thorpe S.R. Formation of o-tyrosine and o,o′-dityrosine in proteins during radiolytic and metal-catalyzed oxidation. J Biol Chem. 268:1993;12341-12347.
23. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico . Lancet. 354:1999;447-455.
24. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;154-160.
25. de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk a randomised trial in general practice. Collaborative Group of the Primary Prevention Project . Lancet. 357:2001;89-95.
26. Heinecke J.W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol. 21:2001;1261-1264.
27. Savenkova M.I., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 269:1994;20394-20400.
28. Thomas S.R., Stocker R. Molecular action of vitamin E in lipoprotein oxidation implications for atherosclerosis . Free Radic Biol Med. 28:2000;1795-1805.
29. Cho A., Graves J., Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:2000;2527-2532.
30. Aikawa M., Rabkin E., Sugiyama S., Voglic S.J., Fukumoto Y., Furukawa Y., Shiomi M., Schoen F.J., Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 103:2001;276-283.
31. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage-colony stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 158:2001;879-891.
32. Woessner J.F., Nagase H. Matrix Metalloproteinases and TIMPs. 2000;Oxford University Press, New York.
33. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 276:2001;41279-41287.
34. Leeuwenburgh C., Hansen P.A., Holloszy J.O., Heinecke J.W. Oxidized amino acids in the urine of aging rats potential markers for assessing oxidative stress in vivo . Am J Physiol. 276:1999;R128-R135.
35. Gaut J.P., Byun J., Tran H.D., Heinecke J.W. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography/mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem. 300:2002;252-259.
36. Bhattacharjee S., Pennathur S., Byun J., Crowley J., Mueller D., Gischler J., Hotchkiss R.S., Heinecke J.W. The NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys. 395:2001;69-77.